TR199800645T1 - Apoptoz oraninin arttirilmasi için bir y-RAR-özgü agonist ligandinin kullanimi. - Google Patents
Apoptoz oraninin arttirilmasi için bir y-RAR-özgü agonist ligandinin kullanimi.Info
- Publication number
- TR199800645T1 TR199800645T1 TR1998/00645T TR9800645T TR199800645T1 TR 199800645 T1 TR199800645 T1 TR 199800645T1 TR 1998/00645 T TR1998/00645 T TR 1998/00645T TR 9800645 T TR9800645 T TR 9800645T TR 199800645 T1 TR199800645 T1 TR 199800645T1
- Authority
- TR
- Turkey
- Prior art keywords
- apoptosis
- agonist ligand
- rar
- caused
- ligand
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
En azindan bir hücre popülasyonunda apoptoz oraninin arttirilmasi için bir farmasötik bilesimin hazirlanmasi için en azindan bir y-RAR reseptörüne-özgü agonist ligandinin kullanimi olup, burada apoptozun y-RAR reseptörlerinin aktive edilmesiyle uyarilabildigi anlatilmistir.Bilesim, özellikle,apoptozun y-RAR reseptörlerinin aktive edilmesiyle uyarilabildigi, en azindan bir hücre popülasyonunda yetersiz bir apoptoz orani ile iliskili bir hastalik ya da düzensizligin iyilestirilmesi için yararlidir.Bir kozmetik bilesimi içinde apoptoz uyarica olarak en azindan bir y-RAR reseptöre-özgü agonist ligandinin kullanimi da anlatilmistir. Bahsedilen bilesim, derinin kronolojik yaslanmasi ve isikla yaslanmanin kontrol edilmesi ve/veya engellenmesi için kullanilabilecektir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9512179A FR2739557B1 (fr) | 1995-10-09 | 1995-10-09 | Utilisation d'un ligand agoniste specifique rar-gamma |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199800645T1 true TR199800645T1 (tr) | 1998-06-22 |
Family
ID=9483613
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR1998/00645T TR199800645T1 (tr) | 1995-10-09 | 1996-10-08 | Apoptoz oraninin arttirilmasi için bir y-RAR-özgü agonist ligandinin kullanimi. |
Country Status (16)
Country | Link |
---|---|
US (4) | US6593359B1 (tr) |
EP (1) | EP0854710A2 (tr) |
JP (1) | JP3135266B2 (tr) |
KR (1) | KR19990064139A (tr) |
CN (1) | CN1121857C (tr) |
AU (1) | AU705993B2 (tr) |
BR (1) | BR9610967A (tr) |
CA (1) | CA2231561A1 (tr) |
FR (1) | FR2739557B1 (tr) |
HU (1) | HUP9900453A3 (tr) |
NO (1) | NO981592L (tr) |
NZ (1) | NZ319646A (tr) |
PL (1) | PL185826B1 (tr) |
RU (1) | RU2188037C2 (tr) |
TR (1) | TR199800645T1 (tr) |
WO (1) | WO1997013505A2 (tr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9907461D0 (en) * | 1999-03-31 | 1999-05-26 | King S College London | Neurite regeneration |
US20030053991A1 (en) * | 2000-10-04 | 2003-03-20 | Kingsman Alan John | Retinoic acid receptor beta-2, its agonists, and gene theraphy vectors for the treatment of neurological disorders |
US20040266715A1 (en) * | 1999-03-31 | 2004-12-30 | Wong Liang Fong | Neurite regeneration |
US20070213290A1 (en) * | 1996-10-17 | 2007-09-13 | Kingsman Alan J | Neurite regeneration |
FR2757852B1 (fr) | 1996-12-31 | 1999-02-19 | Cird Galderma | Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations |
BR9814957A (pt) * | 1997-11-12 | 2000-10-03 | Hoffmann La Roche | Tratamento de doenças imune mediadas por célula auxiliar "t" tipo 2 com antagonistas retinóides |
US6083973A (en) * | 1998-03-09 | 2000-07-04 | Syntex (U.S.A.) Inc. | Methods for inhibiting mucin secretion using RAR α selective antagonists |
US6949528B1 (en) * | 1998-03-18 | 2005-09-27 | Goddard John G | Compositions containing lysophosphatidic acids which inhibit apoptosis and uses thereof |
JO2178B1 (en) * | 1999-10-19 | 2003-04-23 | اف . هوفمان لاروش ايه جي | Treatment of invasive diseases, using selected anti-PAR materials |
WO2004050101A2 (en) * | 2002-11-29 | 2004-06-17 | Gpc Biotech Ag | Formulations useful against hepatitis c virus infections |
US20050202055A1 (en) | 2004-03-11 | 2005-09-15 | Koichi Shudo, Tokyo, Japan | Anti-wrinkle agent |
JP4921351B2 (ja) * | 2004-03-26 | 2012-04-25 | ディーエスエム アイピー アセッツ ビー.ブイ. | レチノイドと組み合せたhdacインヒビターを含む組成物 |
US7713266B2 (en) | 2005-05-20 | 2010-05-11 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US7850683B2 (en) * | 2005-05-20 | 2010-12-14 | Myoscience, Inc. | Subdermal cryogenic remodeling of muscles, nerves, connective tissue, and/or adipose tissue (fat) |
US9254162B2 (en) | 2006-12-21 | 2016-02-09 | Myoscience, Inc. | Dermal and transdermal cryogenic microprobe systems |
US8409185B2 (en) * | 2007-02-16 | 2013-04-02 | Myoscience, Inc. | Replaceable and/or easily removable needle systems for dermal and transdermal cryogenic remodeling |
WO2009065061A1 (en) | 2007-11-14 | 2009-05-22 | Myoscience, Inc. | Pain management using cryogenic remodeling |
CA2748043A1 (en) | 2008-12-22 | 2010-07-01 | Myoscience, Inc. | Integrated cryosurgical system with refrigerant and electrical power source |
JP5986570B2 (ja) | 2010-09-01 | 2016-09-06 | トーマス・ジェファーソン・ユニバーシティThomas Jefferson University | 筋修復および再生のための組成物および方法 |
EP2723347B1 (en) * | 2011-06-24 | 2019-09-04 | GRI Bio, Inc. | Prevention and treatment of inflammatory conditions |
US9155584B2 (en) | 2012-01-13 | 2015-10-13 | Myoscience, Inc. | Cryogenic probe filtration system |
CA2860893A1 (en) | 2012-01-13 | 2013-07-18 | Myoscience, Inc. | Skin protection for subdermal cryogenic remodeling for cosmetic and other treatments |
EP2802279B1 (en) | 2012-01-13 | 2017-08-16 | Myoscience, Inc. | Cryogenic needle with freeze zone regulation |
US9017318B2 (en) | 2012-01-20 | 2015-04-28 | Myoscience, Inc. | Cryogenic probe system and method |
US9610112B2 (en) | 2013-03-15 | 2017-04-04 | Myoscience, Inc. | Cryogenic enhancement of joint function, alleviation of joint stiffness and/or alleviation of pain associated with osteoarthritis |
WO2014146126A1 (en) | 2013-03-15 | 2014-09-18 | Myoscience, Inc. | Cryogenic blunt dissection methods and devices |
US9295512B2 (en) | 2013-03-15 | 2016-03-29 | Myoscience, Inc. | Methods and devices for pain management |
US10016229B2 (en) | 2013-03-15 | 2018-07-10 | Myoscience, Inc. | Methods and systems for treatment of occipital neuralgia |
WO2015069792A1 (en) | 2013-11-05 | 2015-05-14 | Myoscience, Inc. | Secure cryosurgical treatment system |
EP4098257A1 (en) | 2015-11-25 | 2022-12-07 | IO Therapeutics, Inc. | Use of cyp26-resistant rar alpha selective agonists in the treatment of cancer |
WO2017197323A1 (en) | 2016-05-13 | 2017-11-16 | Lee Ann S | Methods and systems for locating and treating with cold therapy |
CN109310763B (zh) * | 2016-06-10 | 2022-10-21 | Io治疗公司 | 用于癌症免疫疗法的受体选择性类视黄醇和rexinoid化合物和免疫调节剂 |
MX2020000467A (es) | 2017-07-13 | 2020-08-03 | Io Therapeutics Inc | Compuestos retinoides y rexinoides inmunomoduladores en combinacion con inmunomoduladores para inmunoterapia contra cancer. |
KR20200044889A (ko) | 2017-08-31 | 2020-04-29 | 아이오 테라퓨틱스, 인크. | 암 면역요법을 위해 면역 조절제와 조합된 rar 선택적 작용제 |
US11134998B2 (en) | 2017-11-15 | 2021-10-05 | Pacira Cryotech, Inc. | Integrated cold therapy and electrical stimulation systems for locating and treating nerves and associated methods |
US11135236B2 (en) * | 2018-04-10 | 2021-10-05 | Northwestern University | Retinoic acid receptor gamma agonists to attenuate anthracycline-induced cardiotoxicity |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5786391A (en) * | 1995-01-11 | 1998-07-28 | Cornell Research Foundation, Inc. | Regulating gene expression using retinoids with Ch2 OH or related groups at the side chain terminal position |
CA2223489A1 (en) * | 1995-07-17 | 1997-02-06 | Joseph A. Fontana | Method for treating cancer using ahpn |
-
1995
- 1995-10-09 FR FR9512179A patent/FR2739557B1/fr not_active Expired - Fee Related
-
1996
- 1996-10-08 BR BR9610967A patent/BR9610967A/pt not_active Application Discontinuation
- 1996-10-08 EP EP96933502A patent/EP0854710A2/fr not_active Withdrawn
- 1996-10-08 HU HU9900453A patent/HUP9900453A3/hu unknown
- 1996-10-08 KR KR1019980702620A patent/KR19990064139A/ko not_active Application Discontinuation
- 1996-10-08 NZ NZ319646A patent/NZ319646A/xx unknown
- 1996-10-08 RU RU98108590/14A patent/RU2188037C2/ru not_active IP Right Cessation
- 1996-10-08 CN CN96198769A patent/CN1121857C/zh not_active Expired - Fee Related
- 1996-10-08 CA CA002231561A patent/CA2231561A1/fr not_active Abandoned
- 1996-10-08 JP JP09514767A patent/JP3135266B2/ja not_active Expired - Fee Related
- 1996-10-08 WO PCT/FR1996/001568 patent/WO1997013505A2/fr not_active Application Discontinuation
- 1996-10-08 PL PL96326077A patent/PL185826B1/pl not_active IP Right Cessation
- 1996-10-08 TR TR1998/00645T patent/TR199800645T1/tr unknown
- 1996-10-08 US US09/051,407 patent/US6593359B1/en not_active Expired - Fee Related
- 1996-10-08 AU AU72209/96A patent/AU705993B2/en not_active Ceased
-
1998
- 1998-04-07 NO NO981592A patent/NO981592L/no not_active Application Discontinuation
-
1999
- 1999-11-02 US US09/431,920 patent/US6686386B1/en not_active Expired - Fee Related
-
2000
- 2000-07-25 US US09/624,771 patent/US6506796B1/en not_active Expired - Fee Related
-
2001
- 2001-03-09 US US09/801,664 patent/US20010018456A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
HUP9900453A3 (en) | 1999-11-29 |
FR2739557B1 (fr) | 1997-11-14 |
US6686386B1 (en) | 2004-02-03 |
FR2739557A1 (fr) | 1997-04-11 |
HUP9900453A2 (hu) | 1999-05-28 |
KR19990064139A (ko) | 1999-07-26 |
JPH11501661A (ja) | 1999-02-09 |
WO1997013505A2 (fr) | 1997-04-17 |
NZ319646A (en) | 2000-08-25 |
EP0854710A2 (fr) | 1998-07-29 |
NO981592L (no) | 1998-06-09 |
AU7220996A (en) | 1997-04-30 |
CN1121857C (zh) | 2003-09-24 |
PL326077A1 (en) | 1998-08-17 |
BR9610967A (pt) | 1999-03-02 |
AU705993B2 (en) | 1999-06-03 |
CA2231561A1 (fr) | 1997-04-17 |
WO1997013505A3 (fr) | 1997-05-29 |
US6506796B1 (en) | 2003-01-14 |
JP3135266B2 (ja) | 2001-02-13 |
RU2188037C2 (ru) | 2002-08-27 |
US6593359B1 (en) | 2003-07-15 |
PL185826B1 (pl) | 2003-08-29 |
NO981592D0 (no) | 1998-04-07 |
US20010018456A1 (en) | 2001-08-30 |
CN1203528A (zh) | 1998-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199800645T1 (tr) | Apoptoz oraninin arttirilmasi için bir y-RAR-özgü agonist ligandinin kullanimi. | |
DE69421778D1 (de) | Verwendung von wirksamen Mengen von aktiven Stoffen zur Behandlung von Mischhaut | |
DE69720811D1 (de) | L-Ribavirin und dessen Verwendung | |
TR199901973T2 (tr) | Insanin cinsel tepkisini modülasyonu için yöntem ve formülasyonlar. | |
BR9206630A (pt) | Gel cosmético aquoso de baixo pH contendo derivados não iônicos de poliacrilamida | |
DE59609235D1 (de) | Verwendung von aerogelen in der landwirtschaft | |
ES2197500T3 (es) | Uso de cloruro de n,n-bis(fenilcarbamoilmetil)dimetilamonio y sus usos derivados en el tratamiento del dolor cronico. | |
PT788361E (pt) | Novas composicoes a base de uma mistura sinergetica entre pelo menos um ligante de vdr e um retinoide | |
DK0609280T3 (da) | Humane IL-3 varianter | |
DE50007706D1 (de) | Verwendung von melatonin zur behandlung der androgenetischen und diffusen alopezie vom weiblichen typ | |
ES2061419T1 (es) | Derivados de benzofurano y su uso como estabilizadores contra las radiaciones uv. | |
ATE213630T1 (de) | Verwendung vonsisovaleramid als mildes anxiolytisches und sedatives mittel | |
ES2176495T3 (es) | Utilizacion de un antagonista de la bradiquinina, destinada a inducir y/o estimular el crecimiento de los cabellos y/o frenar su caida. | |
MX9302378A (es) | Antagonistas de serotonina. | |
IS4628A (is) | Frumuröð sem myndar kvalastillandi efni til nota í meðferð gegn sársauka | |
ATE293986T1 (de) | Schmerzlindernde verwendung von n-l-alpha- aspartyl-l-phenylalanine-1-methylester | |
DE69903137D1 (de) | Oleamid-glycyl-glycine derivate für die kosmetik und/oder dermatologie | |
FI904144A0 (fi) | Etanolipolttoaine ja sen käyttö dieselpolttoaineena | |
DK89489D0 (da) | Anvendelse af halogenerede allylaminer til fremstilling af et farmaceutisk praeparat | |
DE69326188T2 (de) | Verwendung von N-Acylderivaten von Aminoalkoholen zur Herstellung eines Arzneimittels zur Behandlung von neurogenen endoneuralen Ödemen der peripheren Nerven | |
DE68914454D1 (de) | Pharmazeutische zusammensetzungen und deren verwendung in der behandlung von entzündungen. | |
IT1205111B (it) | Impiego del 2,4-monofurfuriliden-sorbitolo ad uso cosmetico | |
DE60120159D1 (de) | Hautpflegemittel | |
ATE270086T1 (de) | Haarbehandlungsmittel | |
DE69636412D1 (de) | Ginkolide zur hemmung der membranexpression |